⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Quant Healthcare Fund - Regular Plan - Growth | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Quant MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹17.53 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | Nifty Healthcare Index - TRI | BSE Health Care - TRI |
| Fund Manager | Sandeep Tandon | Nikhil Mathur |
| Inception | 17 Jul 2023 | 04 Oct 2023 |
| Returns | ||
| 1Y | 12.76% | 22.64% |
| 3Y | 19.20% | 30.41% |
| 5Y | — | — |
| Since Inception | 18.58% | 29.15% |
| Risk | ||
| 17.18 | 14.07 | |
| 0.96 | 0.59 | |
| 0.74 | 1.59 | |
| -0.01 | 21.67 | |
| 1.56 | 3.48 | |
| -12.21% | -9.23% | |
| Costs | ||
| Expense Ratio | 3.13% | 1.03% |
| Exit Load | 1% on or before 15D, Nil after 15D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Quant MF80%
HDFC MF80%
20.4%Only 20.4% of holdings by weight are common between Quant MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingQuant MFHDFC MF
Divi's Laboratories Ltd.9.63%9.39%
Torrent Pharmaceuticals Ltd.8.62%3.65%
Ipca Laboratories Ltd.5.98%2.98%
Dr. Reddy's Laboratories Ltd.2.33%3.19%
Glenmark Pharmaceuticals Ltd.9.34%2.09%
Category context: Equity vs Equity. Open the full Screener →